149 related articles for article (PubMed ID: 30402041)
1. Upregulation of Plasminogen Activator Inhibitor-1 in Irradiated Recipient Arteries and Veins from Free Tissue Transfer Reconstruction in Cancer Patients.
Eriksson BO; Gahm C; Halle M
Mediators Inflamm; 2018; 2018():4058986. PubMed ID: 30402041
[TBL] [Abstract][Full Text] [Related]
2. Increased long-term expression of pentraxin 3 in irradiated human arteries and veins compared to internal controls from free tissue transfers.
Christersdottir Björklund T; Reilly SJ; Gahm C; Bottazzi B; Mantovani A; Tornvall P; Halle M
J Transl Med; 2013 Sep; 11():223. PubMed ID: 24060373
[TBL] [Abstract][Full Text] [Related]
3. Endothelial activation with prothrombotic response in irradiated microvascular recipient veins.
Halle M; Ekström M; Farnebo F; Tornvall P
J Plast Reconstr Aesthet Surg; 2010 Nov; 63(11):1910-6. PubMed ID: 20079702
[TBL] [Abstract][Full Text] [Related]
4. Long-term endothelial dysfunction in irradiated vessels: an immunohistochemical analysis.
Preidl RHM; Möbius P; Weber M; Amann K; Neukam FW; Kesting M; Geppert CI; Wehrhan F
Strahlenther Onkol; 2019 Jan; 195(1):52-61. PubMed ID: 30324290
[TBL] [Abstract][Full Text] [Related]
5. Urokinase, tissue-type plasminogen activator and plasminogen activator inhibitor-1 expression in severely stenosed and occluded vein grafts with thrombosis.
Sirén V; Kauhanen P; Carpén O; Luther M; Lepäntalo M; Vaheri A; Lassila R
Blood Coagul Fibrinolysis; 2003 Jun; 14(4):369-77. PubMed ID: 12945879
[TBL] [Abstract][Full Text] [Related]
6. Expression of plasminogen activator inhibitor-1 mRNA in healthy, atherosclerotic and thrombotic human arteries and veins.
Arnman V; Nilsson A; Stemme S; Risberg B; Rymo L
Thromb Res; 1994 Dec; 76(5):487-99. PubMed ID: 7900096
[TBL] [Abstract][Full Text] [Related]
7. mRNA expression of urokinase and plasminogen activator inhibitor-1 in human crescentic glomerulonephritis.
Lee HS; Park SY; Moon KC; Hong HK; Song CY; Hong SY
Histopathology; 2001 Aug; 39(2):203-9. PubMed ID: 11493338
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of uPA, PAI-1, and alpha-SMA in aneurysms of patients with perimembranous ventricular septal defect.
Qian J; Sun K; Shen P; Yin MZ
J Heart Valve Dis; 2012 May; 21(3):377-83. PubMed ID: 22808843
[TBL] [Abstract][Full Text] [Related]
9. Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: a potential factor predisposing to thrombosis and its persistence.
Sobel BE; Woodcock-Mitchell J; Schneider DJ; Holt RE; Marutsuka K; Gold H
Circulation; 1998 Jun; 97(22):2213-21. PubMed ID: 9631870
[TBL] [Abstract][Full Text] [Related]
10. Lack of evidence for secretion of plasminogen activator inhibitor-1 by human subcutaneous adipose tissue in vivo.
Yudkin JS; Coppack SW; Bulmer K; Rawesh A; Mohamed-Ali V
Thromb Res; 1999 Oct; 96(1):1-9. PubMed ID: 10554079
[TBL] [Abstract][Full Text] [Related]
11. Tissue factor, plasminogen activator inhibitor-1, and thrombin receptor expression in human crescentic glomerulonephritis.
Grandaliano G; Gesualdo L; Ranieri E; Monno R; Schena FP
Am J Kidney Dis; 2000 Apr; 35(4):726-38. PubMed ID: 10739796
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of plasminogen activator inhibitor-1 expression in different types of atherosclerotic lesions in coronary arteries from human heart explants.
Padró T; Steins M; Li CX; Mesters RM; Hammel D; Scheld HH; Kienast J
Cardiovasc Res; 1997 Oct; 36(1):28-36. PubMed ID: 9415269
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous distribution of macrophages, tumour necrosis factor alpha, tissue factor and fibrinolytic regulators in atherosclerotic vessels.
Falkenberg M; Björnheden T; Odén A; Risberg B
Eur J Vasc Endovasc Surg; 1998 Oct; 16(4):276-83. PubMed ID: 9818004
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen Activator Inhibitor-1 Promotes the Recruitment and Polarization of Macrophages in Cancer.
Kubala MH; Punj V; Placencio-Hickok VR; Fang H; Fernandez GE; Sposto R; DeClerck YA
Cell Rep; 2018 Nov; 25(8):2177-2191.e7. PubMed ID: 30463014
[TBL] [Abstract][Full Text] [Related]
15. Suppression of plasminogen activator inhibitor-1 release from human cerebral endothelium by plasminogen activators. A factor potentially predisposing to intracranial bleeding.
Shatos MA; Doherty JM; Penar PL; Sobel BE
Circulation; 1996 Aug; 94(4):636-42. PubMed ID: 8772682
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor-1 in neointima of vein grafts: its role in reduced fibrinolytic potential and graft failure.
Kauhanen P; Sirén V; Carpén O; Vaheri A; Lepäntalo M; Lassila R
Circulation; 1997 Sep; 96(6):1783-9. PubMed ID: 9323062
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of arterial endothelial cell expression of the plasminogen activator inhibitor type-1 (PAI-1) gene by proinsulin and insulin in vivo.
Nordt TK; Sawa H; Fujii S; Bode C; Sobel BE
J Mol Cell Cardiol; 1998 Aug; 30(8):1535-43. PubMed ID: 9737940
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical properties in the patients with Buerger's disease--possible role of plasminogen activator inhibitor-1 for preservation of vessel wall architecture.
Sato T; Tamai H; Kobayashi M; Yamamoto K; Komori K
Cardiovasc Pathol; 2011; 20(5):266-71. PubMed ID: 20708412
[TBL] [Abstract][Full Text] [Related]
19. The urokinase-type plasminogen activator and inhibitors in resectable lung adenocarcinoma.
Zhu C; Jiang L; Xu J; Ren A; Ju F; Shu Y
Pathol Res Pract; 2020 Apr; 216(4):152885. PubMed ID: 32113794
[TBL] [Abstract][Full Text] [Related]
20. C-type natriuretic peptide (CNP) suppresses plasminogen activator inhibitor-1 (PAI-1) in vivo.
Kairuz EM; Barber MN; Anderson CR; Kanagasundaram M; Drummond GR; Woods RL
Cardiovasc Res; 2005 Jun; 66(3):574-82. PubMed ID: 15914122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
